New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Immune cell health discovery could optimise cancer therapies

Immune cell health discovery could optimise cancer therapies

byUniversity College LondonCredit: CC0 Public DomainScientists at UCL have discovered how immune cells, essential for tackling life-threatening infections and cancers, are able to 'recycle&#
World medicine December 13,2023
Immune cell health discovery could optimise cancer therapies

Immune cell health discovery could optimise cancer therapies

byUniversity College LondonCredit: CC0 Public DomainScientists at UCL have discovered how immune cells, essential for tackling life-threatening infections and cancers, are able to 'recycle&#
World medicine December 13,2023
New lung immuno-oncology therapeutic strategy identified

New lung immuno-oncology therapeutic strategy identified

byThe Mount Sinai HospitalDenoted in red, with tumor cells illuminated in green, TREM2 macrophages heavily infiltrate and occupy lung cancer lesions. Credit: Park et al.,Nature ImmunologyR
World medicine December 13,2023
New lung immuno-oncology therapeutic strategy identified

New lung immuno-oncology therapeutic strategy identified

byThe Mount Sinai HospitalDenoted in red, with tumor cells illuminated in green, TREM2 macrophages heavily infiltrate and occupy lung cancer lesions. Credit: Park et al.,Nature ImmunologyR
World medicine December 13,2023
Roll up your sleeve and donate blood for cancer patients

Roll up your sleeve and donate blood for cancer patients

Many people don't realize that cancer patients are in constant need of blood supplies.Chemotherapy and radiation treatments for cancer can damage the body's ability to producehealthy blo
World medicine December 13,2023
Roll up your sleeve and donate blood for cancer patients

Roll up your sleeve and donate blood for cancer patients

Many people don't realize that cancer patients are in constant need of blood supplies.Chemotherapy and radiation treatments for cancer can damage the body's ability to producehealthy blo
World medicine December 13,2023
Can a second opinion make a difference?

Can a second opinion make a difference?

by Kathy Katella,Yale UniversityCredit: CC0 Public DomainYour doctor may be the smartest, most compassionate, thoughtful person in the world—a leading specialist or someone you've trusted fo
World medicine December 13,2023
Can a second opinion make a difference?

Can a second opinion make a difference?

by Kathy Katella,Yale UniversityCredit: CC0 Public DomainYour doctor may be the smartest, most compassionate, thoughtful person in the world—a leading specialist or someone you've trusted fo
World medicine December 13,2023
Canine Tumor Genome Atlas will map DNA in pets to help people with cancer

Canine Tumor Genome Atlas will map DNA in pets to help people with cancer

byUC DavisCredit: Pixabay/CC0 Public DomainPioneering work in comparative oncology continues at UC Davis with the launch of a Canine Tumor Genome Atlas, the first genomic data bank of its kind o
World medicine December 13,2023
Canine Tumor Genome Atlas will map DNA in pets to help people with cancer

Canine Tumor Genome Atlas will map DNA in pets to help people with cancer

byUC DavisCredit: Pixabay/CC0 Public DomainPioneering work in comparative oncology continues at UC Davis with the launch of a Canine Tumor Genome Atlas, the first genomic data bank of its kind o
World medicine December 13,2023
Researchers identify novel protein to prevent neuropathy from chemotherapy

Researchers identify novel protein to prevent neuropathy from chemotherapy

by National University of Singapore, Yong Loo Lin School of MedicineCredit: CC0 Public DomainA team of researchers from the NUS Yong Loo Lin School of Medicine has identified a novel protein that woul
World medicine December 13,2023
Researchers identify novel protein to prevent neuropathy from chemotherapy

Researchers identify novel protein to prevent neuropathy from chemotherapy

by National University of Singapore, Yong Loo Lin School of MedicineCredit: CC0 Public DomainA team of researchers from the NUS Yong Loo Lin School of Medicine has identified a novel protein that woul
World medicine December 13,2023
Study examines genetic testing in diverse young breast cancer patients over a decade

Study examines genetic testing in diverse young breast cancer patients over a decade

byFlorida Atlantic UniversityCredit: CC0 Public DomainBreast cancer patients diagnosed under age 50 represent 18 percent of new invasive breast cancer cases in the United States. Compared to pos
World medicine December 13,2023
Study examines genetic testing in diverse young breast cancer patients over a decade

Study examines genetic testing in diverse young breast cancer patients over a decade

byFlorida Atlantic UniversityCredit: CC0 Public DomainBreast cancer patients diagnosed under age 50 represent 18 percent of new invasive breast cancer cases in the United States. Compared to pos
World medicine December 13,2023
Whole-body PET/CT predicts response to HER2-targeted therapy in metastatic breast cancer patients

Whole-body PET/CT predicts response to HER2-targeted therapy in metastatic breast cancer patients

bySociety of Nuclear Medicine68Ga-ABY-025 PET/CT and18F-FDG PET/CT images at baseline with18F-FDG PET/CT follow-up after 2 cycles of treatment in biopsy-confirmed HER2-positive disea
World medicine December 13,2023
Whole-body PET/CT predicts response to HER2-targeted therapy in metastatic breast cancer patients

Whole-body PET/CT predicts response to HER2-targeted therapy in metastatic breast cancer patients

bySociety of Nuclear Medicine68Ga-ABY-025 PET/CT and18F-FDG PET/CT images at baseline with18F-FDG PET/CT follow-up after 2 cycles of treatment in biopsy-confirmed HER2-positive disea
World medicine December 13,2023
Towards better anti-cancer drugs: New insights into CDK8, an important human oncogene

Towards better anti-cancer drugs: New insights into CDK8, an important human oncogene

byBayreuth UniversityFelix Klatt utilizes an ÄKTA chromatography system to purify protein complexes that were instrumental to the publication. Credit: Juergen Rennecke.Most cancers are caused by
World medicine December 13,2023
Towards better anti-cancer drugs: New insights into CDK8, an important human oncogene

Towards better anti-cancer drugs: New insights into CDK8, an important human oncogene

byBayreuth UniversityFelix Klatt utilizes an ÄKTA chromatography system to purify protein complexes that were instrumental to the publication. Credit: Juergen Rennecke.Most cancers are caused by
World medicine December 13,2023
Overall survival in patients with lung adenocarcinoma harboring 'niche' mutations

Overall survival in patients with lung adenocarcinoma harboring 'niche' mutations

by Impact JournalsSurvival curves in the KRAS, EGFR, and niche mutations cohorts. The red line represents the KRAS cohort, the purple line represents the EGFR cohort and the blue line represents the n
World medicine December 13,2023
Overall survival in patients with lung adenocarcinoma harboring 'niche' mutations

Overall survival in patients with lung adenocarcinoma harboring 'niche' mutations

by Impact JournalsSurvival curves in the KRAS, EGFR, and niche mutations cohorts. The red line represents the KRAS cohort, the purple line represents the EGFR cohort and the blue line represents the n
World medicine December 13,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com